Celebrating 25 years Est 1999-2024
*Across 3 years $2276.64 only $1138.32
Pfizer Inc sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used ...
GSK PLC on Thursday said it intended to sell a further chunk of shares in Haleon PLC, the consumer healthcare busines ...
AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rar ...
The US on Monday approved Covid vaccines with formulations that more closely target currently circulating variants, a ...
Pfizer Inc on Thursday said the European Commission has granted marketing authorisation for Abrysvo. The New York Ci ...
Astellas Pharma Inc on Wednesday said the US Food & Drug Administration granted priority review for its supplemental ...
The US on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused ...
GSK PLC on Wednesday sued Pfizer Inc over patent infringement, alleging Pfizer's respiratory syncytial virus vaccine ...
Pfizer Inc on Tuesday reported a significant decline in second-quarter profit and revenue, although sales excluding t ...
GSK PLC on Thursday said it intends to sell part of its stake in consumer healthcare business, Haleon PLC, which it d ...
Pfizer Inc will begin offloading its 32% stake in Haleon PLC as it focuses on reducing debt linked to its USD43 bill ...
Pfizer Inc on Tuesday reaffirmed its full-year guidance, despite reporting a drop in revenue in the first quarter. P ...
Astellas Pharma Inc and Pfizer Inc on Saturday announced that Xtandi plus leuprolide "significantly" reduced the risk ...
US pharmaceutical firm Pfizer inc announced Monday it had reached a deal to buy biotechnology firm Seagen Inc, specia ...
ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.